Literature DB >> 21251012

B cell receptor editing in tolerance and autoimmunity.

Eline T Luning Prak1, Marc Monestier, Robert A Eisenberg.   

Abstract

Receptor editing is the process of ongoing antibody gene rearrangement in a lymphocyte that already has a functional antigen receptor. The expression of a functional antigen receptor will normally terminate further rearrangement (allelic exclusion). However, lymphocytes with autoreactive receptors have a chance at escaping negative regulation by "editing" the specificities of their receptors with additional antibody gene rearrangements. As such, editing complicates the Clonal Selection Hypothesis because edited cells are not simply endowed for life with a single, invariant antigen receptor. Furthermore, if the initial immunoglobulin gene is not inactivated during the editing process, allelic exclusion is violated and the B cell can exhibit two specificities. Here, we describe the discovery of editing, the pathways of receptor editing at the heavy (H) and light (L) chain loci, and current evidence regarding how and where editing happens and what effects it has on the antibody repertoire.
© 2011 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21251012      PMCID: PMC3077556          DOI: 10.1111/j.1749-6632.2010.05877.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  196 in total

1.  Frequencies of multiple IgL chain gene rearrangements in single normal or kappaL chain-deficient B lineage cells.

Authors:  T Yamagami; E ten Boekel; J Andersson; A Rolink; F Melchers
Journal:  Immunity       Date:  1999-09       Impact factor: 31.745

2.  Production of high affinity autoantibodies in autoimmune New Zealand Black/New Zealand white F1 mice targeted with an anti-DNA heavy chain.

Authors:  D Friedmann; N Yachimovich; G Mostoslavsky; Y Pewzner-Jung; A Ben-Yehuda; K Rajewsky; D Eilat
Journal:  J Immunol       Date:  1999-04-15       Impact factor: 5.422

3.  Transitional B cells lose their ability to receptor edit but retain their potential for positive and negative selection.

Authors:  Hongsheng Wang; Jianxun Feng; Chen-Feng Qi; Zhaoyang Li; Herbert C Morse; Stephen H Clarke
Journal:  J Immunol       Date:  2007-12-01       Impact factor: 5.422

4.  Somatic mutation and light chain rearrangement generate autoimmunity in anti-single-stranded DNA transgenic MRL/lpr mice.

Authors:  F Brard; M Shannon; E L Prak; S Litwin; M Weigert
Journal:  J Exp Med       Date:  1999-09-06       Impact factor: 14.307

5.  Atypical VH-D-JH rearrangements in newborn autoimmune MRL mice.

Authors:  K D Klonowski; L L Primiano; M Monestier
Journal:  J Immunol       Date:  1999-02-01       Impact factor: 5.422

6.  Tolerance induction to self-MHC antigens in fetal and neonatal mouse B cells.

Authors:  Stéphane M Caucheteux; Cécile Vernochet; Josiane Wantyghem; Marie-Claude Gendron; Colette Kanellopoulos-Langevin
Journal:  Int Immunol       Date:  2007-11-20       Impact factor: 4.823

7.  Distinct signal thresholds for the unique antigen receptor-linked gene expression programs in mature and immature B cells.

Authors:  R J Benschop; D Melamed; D Nemazee; J C Cambier
Journal:  J Exp Med       Date:  1999-09-20       Impact factor: 14.307

8.  Reduced receptor editing in lupus-prone MRL/lpr mice.

Authors:  Jennifer L Lamoureux; Lisa C Watson; Marie Cherrier; Patrick Skog; David Nemazee; Ann J Feeney
Journal:  J Exp Med       Date:  2007-10-29       Impact factor: 14.307

9.  Rearrangement and expression of immunoglobulin light chain genes can precede heavy chain expression during normal B cell development in mice.

Authors:  T I Novobrantseva; V M Martin; R Pelanda; W Müller; K Rajewsky; A Ehlich
Journal:  J Exp Med       Date:  1999-01-04       Impact factor: 14.307

10.  Multiple, conserved cryptic recombination signals in VH gene segments: detection of cleavage products only in pro B cells.

Authors:  Marco Davila; Feifei Liu; Lindsay G Cowell; Anne E Lieberman; Emily Heikamp; Anjali Patel; Garnett Kelsoe
Journal:  J Exp Med       Date:  2007-12-03       Impact factor: 14.307

View more
  38 in total

1.  TLR9 promotes tolerance by restricting survival of anergic anti-DNA B cells, yet is also required for their activation.

Authors:  Kevin M Nickerson; Sean R Christensen; Jaime L Cullen; Wenzhao Meng; Eline T Luning Prak; Mark J Shlomchik
Journal:  J Immunol       Date:  2013-01-07       Impact factor: 5.422

2.  Loss of an Igκ gene enhancer in mature B cells results in rapid gene silencing and partial reversible dedifferentiation.

Authors:  Xiaorong Zhou; Yougui Xiang; Xiaoling Ding; William T Garrard
Journal:  Mol Cell Biol       Date:  2013-03-18       Impact factor: 4.272

3.  Determinants of VH1-46 Cross-Reactivity to Pemphigus Vulgaris Autoantigen Desmoglein 3 and Rotavirus Antigen VP6.

Authors:  Michael Jeffrey Cho; Christoph T Ellebrecht; Christoph M Hammers; Eric M Mukherjee; Gopal Sapparapu; Crystal E Boudreaux; Sarah M McDonald; James E Crowe; Aimee S Payne
Journal:  J Immunol       Date:  2016-07-11       Impact factor: 5.422

4.  Clonal Evolution of Autoreactive Germinal Centers.

Authors:  Søren E Degn; Cees E van der Poel; Daniel J Firl; Burcu Ayoglu; Fahd A Al Qureshah; Goran Bajic; Luka Mesin; Claude-Agnès Reynaud; Jean-Claude Weill; Paul J Utz; Gabriel D Victora; Michael C Carroll
Journal:  Cell       Date:  2017-08-24       Impact factor: 41.582

5.  Role of the Igh intronic enhancer Eμ in clonal selection at the pre-B to immature B cell transition.

Authors:  Cheng Peng; Laurel A Eckhardt
Journal:  J Immunol       Date:  2013-09-20       Impact factor: 5.422

Review 6.  Secondary receptor editing in the generation of autoimmunity.

Authors:  Robert A Eisenberg
Journal:  Autoimmun Rev       Date:  2012-02-14       Impact factor: 9.754

7.  Impaired ATM activation in B cells is associated with bone resorption in rheumatoid arthritis.

Authors:  Kofi A Mensah; Jeff W Chen; Jean-Nicolas Schickel; Isabelle Isnardi; Natsuko Yamakawa; Andrea Vega-Loza; Jennifer H Anolik; Richard A Gatti; Erwin W Gelfand; Ruth R Montgomery; Mark C Horowitz; Joe E Craft; Eric Meffre
Journal:  Sci Transl Med       Date:  2019-11-20       Impact factor: 17.956

8.  Caspase-activated DNase is required for maintenance of tolerance to lupus nuclear autoantigens.

Authors:  Neelakshi R Jog; Lorenza Frisoni; Qin Shi; Marc Monestier; Sairy Hernandez; Joe Craft; Eline T Luning Prak; Roberto Caricchio
Journal:  Arthritis Rheum       Date:  2011-11-29

Review 9.  Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity.

Authors:  Sandra M McLachlan; Basil Rapoport
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

10.  Molecular mimicry and clonal deletion: A fresh look.

Authors:  Noel R Rose
Journal:  J Theor Biol       Date:  2014-08-27       Impact factor: 2.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.